News

Tackling antibiotic resistance and exploring the role of genomics in the novel coronavirus are the focus of new funding from the NHMRC, to fight infectious disease.

A future making breakthroughs in inflammation research and sharing knowledge with the next generation of scientists at UQ are the targets for newly minted PhD Amy Chan.

Finding decision-making genes has implications for blocking a cell’s bad decisions when things go wrong in disease or in the environment.

An Australian stinging tree that causes extreme pain to its victims has been transformed into an award-winning artwork for this year’s IMB Jo Underhill Art Award.

A genomics researcher who is investigating the link between heart disease and neurological disease has been named one of Australia’s official Superstars of STEM.

An IMB imaging scientist has secured more than $800,000 from the Chan Zuckerberg Initiative to speed up and automate processing of microscopy data.

Researchers are using tiny fluorescent probes to investigate how and why bacteria are becoming resistant to antibiotics.

Does a doorhandle or a keyboard have more germs?

Genomic pioneer Professor Naomi Wray is one of 28 Fellows elected to the Australian Academy of Health and Medical Sciences in 2020.

An international team has found a way to potentially prevent the novel coronavirus from infecting cells, as well as clues as to why it is more infectious than similar viruses.

Droplets of fat inside our cells are helping us fight back against infection.

Scientists have found a new piece of DNA essential to forming male sex organs in mice

A gene that helps to control inflammation increases the risk of obesity and could be turned off in mice to stop weight gain.

IMB's Professor Robert Parton and AIBN's Professor Kristofer Thurecht are Eureka Prize finalists for their project using VR to solve the problem of visualising complex data.

IMB researchers have proven they top the state, with two of the three winners of the Queensland Women in STEM awards going to the Institute.

A key discovery on the immune system’s powerful defence against bacteria will contribute to global efforts to design immune-boosting treatments.

Inflazome, a startup company developing treatments for inflammatory diseases based on a research partnership between The University of Queensland and Trinity College Dublin (TCD) has been acquired in a landmark deal by Roche.

Molecules from the venom of one of the world’s largest spiders could help tailor pain blockers for people with irritable bowel syndrome (IBS).

IMB researchers have discovered the neurotoxin in the giant stinging tree targets the same receptors as spider and cone snail toxins.

A healthy gut might be impacting the longevity of people living with Motor Neurone Disease (MND), but not in the way you may first suspect.